Elevated levels of inflammatory biomarkers, such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), have been associated with poor stroke outcomes, including increased mortality, disability, and recurrent stroke risk [8–10]. This evidence concerns the gene CRP and stroke disorder.